Lv5
1180 积分 2023-09-24 加入
JOSHA`s CRITICAL REVIEW OF „Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer”
1个月前
已完结
SurvdigitizeR: an algorithm for automated survival curve digitization
1个月前
已完结
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
1个月前
已完结
BEAT-SC: A randomized phase III study of bevacizumab or placebo in combination with atezolizumab and platinum-based chemotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC)
3个月前
已关闭
Socioeconomic disparities in survival outcomes of patients with SCLC with brain metastases: A nationwide analysis
3个月前
已关闭
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
3个月前
已完结
First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial
3个月前
已完结
Prognostic value of baseline clinicopathological characteristics in first-line chemotherapy ± immunotherapy for extensive-stage small cell lung cancer: a retrospective cohort study
3个月前
已关闭
Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian
3个月前
已完结
Faculty Opinions recommendation of Comprehensive genomic profiles of small cell lung cancer
3个月前
已关闭
皖公网安备34019202002308
